Innovex International Reports Q4 Profit Decline
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 23 2026
0mins
Should l Buy INVX?
Source: NASDAQ.COM
- Profit Decline: Innovex International reported a fourth-quarter profit of $13.96 million, or $0.20 per share, which is a significant drop from last year's $31.78 million and $0.47 per share, indicating pressure on profitability.
- Revenue Growth: Despite the profit decline, the company's revenue increased by 9.1% year-over-year to $273.60 million, up from $250.68 million last year, demonstrating potential for sales growth.
- Future Guidance: The company provided revenue guidance for the next quarter in the range of $225 million to $235 million, reflecting a cautiously optimistic outlook from management despite the current profit decline.
- Market Reaction: The significant drop in profit may raise investor concerns about the company's future profitability, potentially impacting stock performance, especially in a competitive market environment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INVX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INVX
Wall Street analysts forecast INVX stock price to fall
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 25.720
Low
20.00
Averages
23.50
High
27.00
Current: 25.720
Low
20.00
Averages
23.50
High
27.00
About INVX
Innovex International, Inc. designs, manufactures, sells and rents a broad suite of well-centric, engineered products to the global oil and natural gas industry. The Company’s products are sold and rented to international oil companies, national oil companies, independent exploration and production companies and multinational service companies. The products it provides have applications across the well lifecycle for both onshore and offshore oil and natural gas wells, including well construction, well completion, and well production and intervention applications. The Company's products include subsea wellheads, subsea wellhead connectors, subsea services, surface/platform unitized systems, drilling wellheads, frac solutions, production wellheads, thermal wellheads, reamers & stabilizers, drilling enhancement tools, penetrators & connectors, surefire power charges, casing flotation subs, gas lift systems, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Marriott Vacations Reports Strong Q4, Shares Surge
- Earnings Beat: Marriott Vacations reported an adjusted EPS of $1.86 for Q4, surpassing market expectations of $1.57, which highlights the company's strong profitability and boosts investor confidence.
- Sales Growth: The company's quarterly sales reached $1.323 billion, exceeding the anticipated $1.294 billion, indicating sustained competitiveness in the market and enhancing shareholder value.
- Stock Surge: In pre-market trading, Marriott Vacations shares jumped 12.7% to $65.34, reflecting market optimism about the company's future growth potential and likely attracting more investor interest.
- Positive Guidance: The company also issued FY26 adjusted EPS guidance above estimates, further solidifying its leadership position in the vacation industry and laying a strong foundation for future growth.
See More
Innovex International Prices Public Offering at $25.75
- Public Offering Pricing: Innovex International has priced its underwritten public offering at $25.75 per share for 5.75 million shares, a price that may be perceived as unfavorable, potentially impacting the stock negatively.
- Additional Share Option: The underwriters have a 30-day option to purchase an additional 862,500 shares, which could dilute existing shareholders' equity further, adding uncertainty to the market.
- Closing Date: The offering is expected to close on February 27, 2026, and investors should monitor this date to assess its potential impact on the company's financial health.
- Stock Price Decline: Following the public offering announcement, Innovex's stock price fell by 8% during after-market trading on Wednesday, indicating a negative market reaction that could affect investor confidence.
See More
Innovex International Announces Pricing of Stock Offering
- Stock Offering Pricing: Innovex International has priced an underwritten offering of 5.75 million shares at $25.75 each, expected to close on February 27, 2026, indicating the company's active engagement in capital markets.
- Additional Purchase Option: The selling stockholders granted underwriters a 30-day option to purchase up to 862,500 additional shares, enhancing market liquidity and investor confidence.
- Share Repurchase Plan: Following the offering, Innovex intends to repurchase 575,000 shares at the offering price, reflecting the company's confidence in its stock value and potentially boosting earnings per share.
- Underwriter Lineup: J.P. Morgan, Citigroup, Jefferies, and Piper Sandler are acting as joint book-running managers for the offering, showcasing market recognition and support for Innovex.
See More
Innovex International Announces Public Offering of 5.75 Million Shares
- Offering Size: Innovex International has announced a public offering of 5.75 million shares of common stock by certain affiliates of Amberjack Capital Partners, L.P., with an additional 30-day option for underwriters to purchase 862,500 shares, indicating the company's active engagement in capital markets.
- Funding Dynamics: Innovex will not sell any shares in the offering and will not receive proceeds, which suggests a focus on shareholder interests rather than direct financing, potentially impacting short-term liquidity.
- Share Repurchase Plan: The company intends to repurchase up to $15 million or 10% of the shares from the offering, reflecting confidence in its stock value while providing additional returns to shareholders.
- Underwriter Lineup: J.P. Morgan, Citigroup, Jefferies, and Piper Sandler are acting as joint book-running managers for the offering, demonstrating market trust and support for Innovex, which may enhance investor confidence in the company's future growth.
See More
Innovex International Launches 5.75 Million Share Public Offering
- Public Offering Size: Innovex International announced a public offering led by Amberjack Capital Partners involving 5.75 million shares of common stock, with selling stockholders expected to grant underwriters a 30-day option to purchase an additional 862,500 shares, thereby enhancing market liquidity.
- No Company Participation: Innovex stated that it will not sell any shares in this offering and will not receive any proceeds from the sale by selling stockholders, indicating a focus on the interests of existing shareholders rather than short-term financing.
- Share Repurchase Plan: The company intends to purchase shares from the underwriters for the lesser of 10% or $15 million of the offering, demonstrating confidence in its stock value and aiming to enhance shareholder value through buybacks.
- Market Reaction: Following the announcement, Innovex's stock price fell 1.57% in after-hours trading to $28.79, reflecting a cautious market sentiment regarding the offering and potentially impacting investor expectations for the company's future performance.
See More
Innovex International Announces Public Offering of 5.75 Million Shares
- Offering Size: Innovex International announced a public offering of 5.75 million shares of common stock by certain affiliates of Amberjack Capital Partners, L.P., with an additional 30-day option for underwriters to purchase up to 862,500 shares, indicating the company's active engagement in capital markets.
- Funding Dynamics: Innovex will not sell any shares nor receive proceeds from the offering, highlighting a strategy that relies on shareholder capital movements rather than direct financing, which may affect investor perceptions.
- Share Repurchase Plan: The company intends to repurchase up to 10% or $15 million of the shares from the underwriters, reflecting confidence in its stock value and potentially enhancing long-term investor trust in the company.
- Underwriter Lineup: J.P. Morgan, Citigroup, Jefferies, and Piper Sandler are acting as joint book-running managers for the offering, underscoring the professionalism and market credibility of the transaction, which may enhance the company's image among investors.
See More
Marriott Vacations Reports Strong Q4, Shares Surge
- Earnings Beat: Marriott Vacations reported an adjusted EPS of $1.86 for Q4, surpassing market expectations of $1.57, which highlights the company's strong profitability and boosts investor confidence.
- Sales Growth: The company's quarterly sales reached $1.323 billion, exceeding the anticipated $1.294 billion, indicating sustained competitiveness in the market and enhancing shareholder value.
- Stock Surge: In pre-market trading, Marriott Vacations shares jumped 12.7% to $65.34, reflecting market optimism about the company's future growth potential and likely attracting more investor interest.
- Positive Guidance: The company also issued FY26 adjusted EPS guidance above estimates, further solidifying its leadership position in the vacation industry and laying a strong foundation for future growth.
See More
Innovex International Prices Public Offering at $25.75
- Public Offering Pricing: Innovex International has priced its underwritten public offering at $25.75 per share for 5.75 million shares, a price that may be perceived as unfavorable, potentially impacting the stock negatively.
- Additional Share Option: The underwriters have a 30-day option to purchase an additional 862,500 shares, which could dilute existing shareholders' equity further, adding uncertainty to the market.
- Closing Date: The offering is expected to close on February 27, 2026, and investors should monitor this date to assess its potential impact on the company's financial health.
- Stock Price Decline: Following the public offering announcement, Innovex's stock price fell by 8% during after-market trading on Wednesday, indicating a negative market reaction that could affect investor confidence.
See More
Innovex International Announces Pricing of Stock Offering
- Stock Offering Pricing: Innovex International has priced an underwritten offering of 5.75 million shares at $25.75 each, expected to close on February 27, 2026, indicating the company's active engagement in capital markets.
- Additional Purchase Option: The selling stockholders granted underwriters a 30-day option to purchase up to 862,500 additional shares, enhancing market liquidity and investor confidence.
- Share Repurchase Plan: Following the offering, Innovex intends to repurchase 575,000 shares at the offering price, reflecting the company's confidence in its stock value and potentially boosting earnings per share.
- Underwriter Lineup: J.P. Morgan, Citigroup, Jefferies, and Piper Sandler are acting as joint book-running managers for the offering, showcasing market recognition and support for Innovex.
See More
Innovex International Announces Public Offering of 5.75 Million Shares
- Offering Size: Innovex International has announced a public offering of 5.75 million shares of common stock by certain affiliates of Amberjack Capital Partners, L.P., with an additional 30-day option for underwriters to purchase 862,500 shares, indicating the company's active engagement in capital markets.
- Funding Dynamics: Innovex will not sell any shares in the offering and will not receive proceeds, which suggests a focus on shareholder interests rather than direct financing, potentially impacting short-term liquidity.
- Share Repurchase Plan: The company intends to repurchase up to $15 million or 10% of the shares from the offering, reflecting confidence in its stock value while providing additional returns to shareholders.
- Underwriter Lineup: J.P. Morgan, Citigroup, Jefferies, and Piper Sandler are acting as joint book-running managers for the offering, demonstrating market trust and support for Innovex, which may enhance investor confidence in the company's future growth.
See More
Innovex International Launches 5.75 Million Share Public Offering
- Public Offering Size: Innovex International announced a public offering led by Amberjack Capital Partners involving 5.75 million shares of common stock, with selling stockholders expected to grant underwriters a 30-day option to purchase an additional 862,500 shares, thereby enhancing market liquidity.
- No Company Participation: Innovex stated that it will not sell any shares in this offering and will not receive any proceeds from the sale by selling stockholders, indicating a focus on the interests of existing shareholders rather than short-term financing.
- Share Repurchase Plan: The company intends to purchase shares from the underwriters for the lesser of 10% or $15 million of the offering, demonstrating confidence in its stock value and aiming to enhance shareholder value through buybacks.
- Market Reaction: Following the announcement, Innovex's stock price fell 1.57% in after-hours trading to $28.79, reflecting a cautious market sentiment regarding the offering and potentially impacting investor expectations for the company's future performance.
See More
Innovex International Announces Public Offering of 5.75 Million Shares
- Offering Size: Innovex International announced a public offering of 5.75 million shares of common stock by certain affiliates of Amberjack Capital Partners, L.P., with an additional 30-day option for underwriters to purchase up to 862,500 shares, indicating the company's active engagement in capital markets.
- Funding Dynamics: Innovex will not sell any shares nor receive proceeds from the offering, highlighting a strategy that relies on shareholder capital movements rather than direct financing, which may affect investor perceptions.
- Share Repurchase Plan: The company intends to repurchase up to 10% or $15 million of the shares from the underwriters, reflecting confidence in its stock value and potentially enhancing long-term investor trust in the company.
- Underwriter Lineup: J.P. Morgan, Citigroup, Jefferies, and Piper Sandler are acting as joint book-running managers for the offering, underscoring the professionalism and market credibility of the transaction, which may enhance the company's image among investors.
See More
